Formulation and Comprehensive Evaluation of Biohybrid Hydrogel Membranes Containing Doxycycline or Silver Nanoparticles
Pharmaceutics · 28.11.2023 · 15 (12) · 2696
DOI: 10.3390/pharmaceutics15122696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.11.2023. Verfasst von Diana Stan und 12 weiteren Autor:innen. Beteiligte Einrichtung: DDS Diagnostic, Segovia 1 Str., 031427 Bucharest, Romania. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DDS Diagnostic.
Abstract (Originalsprache)
Complicated wounds often require specialized medical treatments, and hydrogels have emerged as a popular choice for wound dressings in such cases due to their unique properties and the ability to incorporate and release therapeutic agents. Our focus was to develop and characterize a new optimized formula for biohybrid hydrogel membranes, which combine natural and synthetic polymers, bioactive natural compounds, like collagen and hyaluronic acid, and pharmacologically active substances (doxycycline or npAg). Dynamic (oscillatory) rheometry confirmed the strong gel-like properties of the obtained hydrogel membranes. Samples containing low-dose DOXY showed a swelling index of 285.68 ± 6.99%, a degradation rate of 71.6 ± 0.91% at 20 h, and achieved a cumulative drug release of approximately 90% at pH 7.4 and 80% at pH 8.3 within 12 h. The addition of npAg influenced the physical properties of the hydrogel membranes. Furthermore, the samples containing DOXY demonstrated exceptional antimicrobial efficacy against seven selected bacterial strains commonly associated with wound infections and complications. Biocompatibility assessments revealed that the samples exhibited over 80% cell viability. However, the addition of smaller-sized nanoparticles led to decreased cellular viability. The obtained biohybrid hydrogel membranes show favorable properties that render them suitable for application as wound dressings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DDS Diagnostic, Segovia 1 Str., 031427 Bucharest, Romania.
- Doctoral School of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.
- Department of Inorganic, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania.
- Department of Analytical and Physical Chemistry, University of Bucharest, 4-12 Regina Elisabeta Blvd., 030018 Bucharest, Romania.
- National Institute for R&D in Microtechnology, 077190 Bucharest, Romania.
- Research Institute, The University of Bucharest, 060102 Bucharest, Romania.
ORCID-Profile: Diana Stan, Lavinia Liliana Ruta, Marin Micutz, Ana-Maria Enciu
Förderung
- DDS Diagnostic
Zitieren
APA
Stan, D., Ruta, L. L., Bocancia-Mateescu, L. A., Mirica, A. C., Stan, D., Micutz, M., Brincoveanu, O., Enciu, A. M., Codrici, E., Popescu, I. D., Popa, M. L., Rotaru, F., & Tanase, C. (2023). Formulation and Comprehensive Evaluation of Biohybrid Hydrogel Membranes Containing Doxycycline or Silver Nanoparticles. Pharmaceutics, 15(12), 2696. https://doi.org/10.3390/pharmaceutics15122696
Vancouver
Stan D, Ruta LL, Bocancia-Mateescu LA, Mirica AC, Stan D, Micutz M, et al. Formulation and Comprehensive Evaluation of Biohybrid Hydrogel Membranes Containing Doxycycline or Silver Nanoparticles. Pharmaceutics. 2023;15(12):2696. doi:10.3390/pharmaceutics15122696
BibTeX
@article{Stan2023,
author = {Stan, Diana and Ruta, Lavinia Liliana and Bocancia-Mateescu, Lorena-Andreea and Mirica, Andreea-Cristina and Stan, Dana and Micutz, Marin and Brincoveanu, Oana and Enciu, Ana-Maria and Codrici, Elena and Popescu, Ionela Daniela and Popa, Maria Linda and Rotaru, Flaviana and Tanase, Cristiana},
title = {Formulation and Comprehensive Evaluation of Biohybrid Hydrogel Membranes Containing Doxycycline or Silver Nanoparticles},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {12},
pages = {2696},
doi = {10.3390/pharmaceutics15122696}
}
EUVIMED